You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced transitional cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

Not yet recruiting
  • Advanced Solid Tumors Cancer
  • +3 more
  • New York, New York
    Memorial Slone Kettering Cancer Center
Jun 26, 2023

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • (no location specified)
Dec 15, 2022

Urothelial Carcinoma Trial (Avelumab)

Not yet recruiting
  • Urothelial Carcinoma
  • (no location specified)
Oct 26, 2022

Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Transitional Cell Carcinoma, Advanced Cancer, Metastatic Cancer Trial in Austria, Germany (Nivolumab/Ipilimumab)

    Active, not recruiting
    • Transitional Cell Carcinoma
    • +2 more
    • Nivolumab/Ipilimumab
    • Graz, Austria
    • +26 more
    Nov 2, 2021

    Combined Postoperative Radiotherapy With Kidney Sparing Surgery

    Recruiting
    • Locally Advanced
    • Urothelial Carcinoma Ureter
    • Radical surgery
    • Kidney sparing surgery+Postoperative radiotheray
    • Beijing, China
    • +1 more
    Nov 2, 2023

    Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

    Not yet recruiting
    • Advanced Urothelial Carcinoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Oct 9, 2023

    Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

    Not yet recruiting
    • Locally Advanced Urothelial Carcinoma
    • +3 more
    • (no location specified)
    Sep 15, 2022

    Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

    Not yet recruiting
    • Advanced Urothelial Carcinoma
    • Bern, Switzerland
      University Hospital Insel
    Feb 20, 2023

    Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Shanghai, Shanghai, China
      Huadong Hospital Affiliated to Fudan University
    Jun 30, 2022

    Melanoma, Urothelial Carcinoma Trial in China (QLF31907)

    Not yet recruiting
    • Melanoma
    • Urothelial Carcinoma
    • Beijing, Beijing, China
    • +5 more
    Apr 9, 2023

    Avelumab First-Line Maintenance in Canadian People With Advanced

    Not yet recruiting
    • Urinary Bladder Neoplasms
    • +3 more
    • Avelumab first-line maintenance
    • Mississauga, Ontario, Canada
      Bayshore Specialty Rx
    Jan 24, 2023

    Carcinoma, Transitional Cell, HER-2 Gene Amplification Trial in Beijing (Trastuzumab)

    Recruiting
    • Carcinoma, Transitional Cell
    • HER-2 Gene Amplification
    • Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Mar 31, 2022

    Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

    Not yet recruiting
    • Advanced Urothelial Carcinoma
    • Boston, Massachusetts
      VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
    Jan 13, 2023

    Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

    Recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 8, 2023

    Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

    Not yet recruiting
    • Urothelial Carcinoma
    • disitamab vedotin
    • +4 more
    • (no location specified)
    Jun 9, 2023

    Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

    Not yet recruiting
    • Urothelial Carcinoma
    • Metastatic Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Nov 28, 2022

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)

    Active, not recruiting
    Has Results
    • Urothelial Carcinoma Associated 1 RNA, Human
    • Pembrolizumab
    • +3 more
    • (no location specified)
    Aug 18, 2022

    Urothelial Carcinoma Trial in Amsterdam (Tremelimumab, Durvalumab, Paclitaxel)

    Active, not recruiting
    • Urothelial Carcinoma
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek Ziekenhuis
    Jul 7, 2022

    Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

    Active, not recruiting
    • Urinary Bladder Cancer
    • München, Germany
    • +2 more
    Oct 19, 2022

    Carcinoma, Transitional Cell Trial in Beijing (nanoparticle albumin-bound paclitaxel, S-1, Gemcitabine, cisplatin)

    Completed
    • Carcinoma, Transitional Cell
    • nanoparticle albumin-bound paclitaxel, S-1
    • Gemcitabine, cisplatin
    • Beijing, China
      Chinese PLA General Hospital
    Aug 5, 2021